Atrial Septal Defects
|
0.100 |
GeneticVariation
|
group |
CLINVAR |
|
|
|
Hernia, Inguinal
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Umbilical hernia
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Syncope
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Torticollis
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Broad nasal tip
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Broad thumbs
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Delayed speech and language development
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Recurrent otitis media
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Coarse facial features
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Aplasia/Hypoplasia of the nails
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Cleft anterior mitral valve leaflet
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Acid reflux
|
0.100 |
GeneticVariation
|
phenotype |
CLINVAR |
|
|
|
Cervix carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
We found that BAF53 knockdown led to suppression of expression of E6 and E7 genes from HPV integrants in cervical carcinoma cell lines HeLa and SiHa.
|
21821000 |
2011 |
Spina Bifida Cystica
|
0.200 |
Biomarker
|
disease |
RGD |
miR-9*- and miR-124a-Mediated switching of chromatin remodelling complexes is altered in rat spina bifida aperta.
|
23677776 |
2013 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
These results indicate that failure to downregulate the BAF53a subunit may contribute to the pathogenesis of RMS, and suggest that BAF53a may represent a novel therapeutic target for this tumor.
|
23728344 |
2014 |
Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that failure to downregulate the BAF53a subunit may contribute to the pathogenesis of RMS, and suggest that BAF53a may represent a novel therapeutic target for this tumor.
|
23728344 |
2014 |
Childhood Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that failure to downregulate the BAF53a subunit may contribute to the pathogenesis of RMS, and suggest that BAF53a may represent a novel therapeutic target for this tumor.
|
23728344 |
2014 |
Adult Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that failure to downregulate the BAF53a subunit may contribute to the pathogenesis of RMS, and suggest that BAF53a may represent a novel therapeutic target for this tumor.
|
23728344 |
2014 |
Neoplasm Metastasis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Mechanistically, ACTL6A promotes metastasis and EMT through activating Notch signaling.
|
26698646 |
2016 |
Liver carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
A high level of ACTL6A in HCCs is correlated with aggressive clinicopathological features and is an independent poor prognostic factor for overall and disease-free survival of HCC patients.
|
26698646 |
2016 |
Intellectual Disability
|
0.310 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Thus, ACTL6A gene mutation analysis should be considered in patients with intellectual disability, learning disabilities, or developmental language disorder.
|
28649782 |
2017 |
Intellectual Disability
|
0.310 |
GeneticVariation
|
group |
BEFREE |
Thus, ACTL6A gene mutation analysis should be considered in patients with intellectual disability, learning disabilities, or developmental language disorder.
|
28649782 |
2017 |
Developmental delay (disorder)
|
0.300 |
Biomarker
|
phenotype |
GENOMICS_ENGLAND |
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability.
|
28649782 |
2017 |
Global developmental delay
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability.
|
28649782 |
2017 |